{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T15:32:45Z","timestamp":1783092765864,"version":"3.54.6"},"reference-count":21,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007337","name":"Massachusetts Eye and Ear","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.oret.2022.05.006","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T19:04:36Z","timestamp":1652727876000},"page":"1089-1097","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["A Comparison of Treatment Outcomes after Standard Dose (70 Gy) versus Reduced Dose (50 Gy) Proton Radiation in Patients with Uveal Melanoma"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7321-4419","authenticated-orcid":false,"given":"Anne Marie","family":"Lane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica M.","family":"Oxenreiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Hashmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Aronow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexei V.","family":"Trofimov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen A.","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos S.","family":"Gragoudas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana K.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2022.05.006_bib1","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1001\/archopht.120.12.1665","article-title":"Evidence-based estimates of outcome in patients irradiated for intraocular melanoma","volume":"120","author":"Gragoudas","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2022.05.006_bib2","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0360-3016(01)01560-7","article-title":"Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma","volume":"51","author":"Egger","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.oret.2022.05.006_bib3","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.ijrobp.2005.01.016","article-title":"Proton beam radiotherapy of choroidal melanoma: the Liverpool-Clatterbridge experience","volume":"62","author":"Damato","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.oret.2022.05.006_bib4","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ijrobp.2006.01.020","article-title":"Proton beam radiotherapy for uveal melanoma: results of Curie Institut\u2013Orsay Proton Therapy Center (ICPO)","volume":"65","author":"Dendale","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.oret.2022.05.006_bib5","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1002\/1097-0142(197612)38:6<2258::AID-CNCR2820380611>3.0.CO;2-H","article-title":"Radiation therapy of malignant melanoma: experience with high individual treatment doses","volume":"38","author":"Habermalz","year":"1976","journal-title":"Cancer"},{"key":"10.1016\/j.oret.2022.05.006_bib6","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/0360-3016(82)90060-8","article-title":"The radioresponsiveness of melanoma","volume":"8","author":"Doss","year":"1982","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.oret.2022.05.006_bib7","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijrobp.2016.01.040","article-title":"Practice patterns analysis of ocular proton therapy centers: the international OPTIC survey","volume":"95","author":"Hrbacek","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.oret.2022.05.006_bib8","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0161-6420(87)33439-6","article-title":"Uveal melanomas near the optic disc or fovea. Visual results after proton beam irradiation","volume":"94","author":"Seddon","year":"1987","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2022.05.006_bib9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ophtha.2015.09.031","article-title":"Visual outcomes after proton beam irradiation for choroidal melanomas involving the fovea","volume":"123","author":"Patel","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2022.05.006_bib10","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1001\/archophthalmol.2011.228","article-title":"Proton irradiation for peripapillary and parapapillary melanomas","volume":"129","author":"Lane","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2022.05.006_bib11","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.ophtha.2009.12.015","article-title":"Natural history of radiation papillopathy after proton beam irradiation of parapapillary melanoma","volume":"117","author":"Kim","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2022.05.006_bib12","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S0161-6420(99)90455-4","article-title":"Risk factors for radiation maculopathy and papillopathy after intraocular irradiation","volume":"106","author":"Gragoudas","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2022.05.006_bib13","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.ajo.2014.02.032","article-title":"Proton beam therapy of parapapillary choroidal melanoma","volume":"157","author":"Riechardt","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2022.05.006_bib14","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s10792-020-01594-z","article-title":"Good long-term visual outcomes of parapapillary choroidal melanoma patients treated with proton therapy: a comparative study","volume":"41","author":"Pica","year":"2021","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.oret.2022.05.006_bib15","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/archopht.118.6.773","article-title":"A\u00a0randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma","volume":"118","author":"Gragoudas","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2022.05.006_bib16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1118\/1.595258","article-title":"Planning proton therapy of the eye","volume":"10","author":"Goitein","year":"1983","journal-title":"Med Phys"},{"key":"10.1016\/j.oret.2022.05.006_bib17","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S0360-3016(02)02851-1","article-title":"The Gray lecture 2001: coming technical advances in radiation oncology","volume":"53","author":"Suit","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.oret.2022.05.006_bib18","first-page":"T2","article-title":"Ranibizumab for the prevention of radiation complications in patients treated with proton beam irradiation for choroidal melanoma","volume":"114","author":"Kim","year":"2016","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.oret.2022.05.006_bib19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/jnci\/84.3.155","article-title":"Proton beams in radiation therapy","volume":"84","author":"Suit","year":"1992","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.oret.2022.05.006_bib20","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1097\/IAE.0000000000002200","article-title":"Intravitreal anti-vascular endothelial growth factor treatment at 2-month intervals reduces foveal avascular zone enlargement and vision loss in radiation maculopathy: a pilot study","volume":"39","author":"Daruich","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.oret.2022.05.006_bib21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ajo.2016.04.024","article-title":"Antiangiogenic or corticosteroid treatment in patients with radiation maculopathy after proton beam therapy for uveal melanoma","volume":"168","author":"Seibel","year":"2016","journal-title":"Am J Ophthalmol"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653022002408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653022002408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:31:25Z","timestamp":1762853485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653022002408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S2468653022002408"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2022.05.006","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Comparison of Treatment Outcomes after Standard Dose (70 Gy) versus Reduced Dose (50 Gy) Proton Radiation in Patients with Uveal Melanoma","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2022.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}